Cell Source, Inc. is a biotechnology company, which focuses on developing cell therapy treatments based on the management of immune tolerance. The company is headquartered in New York City, New York. The company went IPO on 2014-01-14. The firm is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management technology. Its Veto Cell technology is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is in pre-clinical phase, and its data shows that it provides results in allogeneic (donor-derived) hematopoietic stem cell transplantation (HSCT) by allowing for haploidentical stem cell transplants under a mild conditioning regimen. Its product pipeline includes chimeric antigen receptor (CAR) T-cell therapies, which include VETO CAR-T (with or without HSCT) for B-cell malignancies, Veto Cell kidney transplants, VETO CAR-T for solid tumors, Veto Cell liver transplants, and Veto HSCT for non-malignant disorders. The firm's wholly owned subsidiary is Cell Source Limited (CSL).
CLCS stock price ended at $0.84 on Thứ Sáu, after rising 10.53%
On the latest trading day Jan 16, 2026, the stock price of CLCS rose by 10.53%, climbing from $0.76 to $0.84. Throughout the session, the stock experienced a volatility of 30.26%, with prices fluctuating between a daily low of $0.76 and a high of $0.99. Alongside this price increase, trading volume also rose by 23.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 23.4K shares were traded, amounting to a market value of approximately $33.6M.
Các Tín hiệu Kỹ thuật của CLCS
Tóm tắt Tín hiệu Kỹ thuật
Mua tín hiệu 5
Tín hiệu trung lập 0
Tín hiệu bán 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
CLCS hiện đang có 5 tín hiệu mua và 2 tín hiệu bán. Cổ phiếu này đã ở trong một xu hướng tăng kể từ 12:00 AM, với mức thay đổi giá tổng cộng là 40% trong giai đoạn này. Nhìn chung, các chỉ báo kỹ thuật cho thấy xu hướng Buy cho trung hạn.
Tín hiệu tăng giá/giảm giá cho CLCS
Phân tích các chỉ báo chính như đường trung bình động, RSI, MACD và khối lượng giao dịch để xác định tín hiệu tăng và giảm giá cho CLCS, giúp bạn đưa ra quyết định đầu tư sáng suốt.
Câu hỏi theo dõi
Comment les indicateurs d'analyse technique s'appliquent-ils à CLCS ?
Quels sont les niveaux de retracement de Fibonacci pour CLCS ?
Quel est le RSI de Cell Source Inc ?
Quel est le prix de Cell Source Inc pour les 12 prochains mois ?